Indonesian Political, Business & Finance News

Siloam and Roche Launch pTau 181 Plasma Test for Early Alzheimer's Detection

| Source: Antara (Indonesian) Translated from Indonesian | Technology
Siloam and Roche Launch pTau 181 Plasma Test for Early Alzheimer's Detection
Image: Antara (Indonesian)

Jakarta (ANTARA) - Siloam International Hospitals, in collaboration with Roche Diagnostics Indonesia, has launched the pTau 181 Plasma blood biomarker testing service in Indonesia. This initiative aims to support the transformation of Alzheimer’s disease detection and early diagnosis through a minimally invasive approach.

Chief Medical Officer of Siloam International Hospitals, Dr Grace Frelita, stated that this innovative step comes as Indonesia enters an era of an ageing population, with the elderly population now exceeding 10 per cent. Consequently, the risk of dementia cases is expected to continue rising.

“This medical breakthrough is also intended to debunk the myth that severe forgetfulness is a normal part of ageing, while emphasising the importance of early medical intervention,” she said.

According to Grace, as Indonesia enters the era of an ageing population, the need for accurate detection and management of cognitive impairment becomes increasingly vital. Therefore, innovation must provide tangible benefits to patients and support doctors with more comprehensive clinical information to help identify patient conditions more precisely.

“With an earlier and more comprehensive understanding of a patient’s condition, we hope this test can provide clarity and confidence in determining the appropriate treatment steps alongside doctors,” Grace added.

Meanwhile, Lee Poh Seng, Director of the Diagnostics Division at PT Roche Indonesia, stated that diagnostic innovation is key to transforming patient care pathways. “The pTau 181 Plasma test is designed to assist doctors and neurologists in conducting more efficient initial evaluations of Alzheimer’s disease,” he said.

The synergy with Siloam International Hospitals ensures that this global-standard technology is accessible to the wider Indonesian public, aiming to provide faster certainty for medical professionals and families.

Clinically, levels of phosphorylated tau 181 (pTau 181) protein in blood plasma have been proven to correlate strongly with the formation of amyloid plaques in the brain, which are primary indicators of Alzheimer’s disease.

He noted that the introduction of the pTau 181 Plasma test brings a breath of fresh air to medical workflows, as the procedure is minimally invasive, requiring only a routine blood sample without the need for painful procedures.

To date, the Alzheimer’s diagnosis process has generally relied on time-consuming clinical tests and further invasive and expensive examinations, such as lumbar punctures (collection of cerebrospinal fluid) or PET scans.

In conjunction with World Alzheimer’s Day, Siloam International Hospitals and Roche Diagnostics Indonesia are calling on the Indonesian public to be more attentive to their family’s brain health and not to dismiss memory loss as a normal occurrence.

More from 9 September 2026 →

Cite this article
Source: jawawa.id (https://jawawa.id/newsitem/siloam-and-roche-launch-ptau-181-plasma-test-for-early-alzheimers-detection-1788973453)
Originally published by Antara (Indonesian) (https://www.antaranews.com/berita/5734036/siloam-roche-luncurkan-tes-ptau-181-plasma-guna-deteksi-dini-alzheimer), translated from Indonesian
Print